Results 31 to 40 of about 40,229 (203)

Extended-Spectrum β-lactamase Production among Enterobacter cloacae and Enterobacter aerogenes at a Tertiary Care Center in Coastal Karnataka [PDF]

open access: yesNational Journal of Laboratory Medicine, 2016
Introduction: Enterobacter spp. have been increasingly isolated as nosocomial pathogens. Multi-drug resistance is more frequently noted among these pathogens. Extended spectrum beta lactamases (ESBLs) are difficult to detect in Enterobacter spp.
Shashidhar Vishwanath   +4 more
doaj   +1 more source

Reconstructing enzyme evolution by protein engineering

open access: yesFEBS Letters, EarlyView.
Natural enzyme evolution can be retraced by protein engineering methods such as directed evolution, rational design, and ancestral sequence reconstruction. These approaches reveal how enzymes emerged from ligand‐binding scaffolds, developed varying substrate preferences, formed oligomeric complexes, adapted to environmental changes, and evolved novel ...
Lukas Drexler   +2 more
wiley   +1 more source

Opsoclonus-myoclonus-encephalopathy induced by cefepime

open access: yes, 2019
•Opsoclonus might be associated with cefepime neurotoxicity.•Cefepime neurotoxicity most commonly presents with myoclonus and encephalopathy.•Continuous video-EEG is vital to monitor for non-convulsive status epilepticus.•Cefepime neurotoxicity occurs in
Kanner, Andres M   +4 more
core   +1 more source

FEP: Cefepime 0.0156μg/ml.

open access: yes, 2015
FEP: Cefepime 0.0156μg/ml.
Kristina Crona (567679)   +5 more
core   +1 more source

Current practice and guideline adherence in renal dose adjustment for patients with chronic kidney disease: A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims To quantify prescribing adherence to renal dosing recommendations in adults with chronic kidney disease (CKD; Stage 3 and above) and to evaluate the clinical consequences of non‐adherence. Methods This systematic review and meta‐analysis was conducted in accordance with PRISMA 2020 guidelines and registered in PROSPERO (CRD42025620883).
Hager ElGeed   +7 more
wiley   +1 more source

Cefepime and mortality: A real issue?

open access: yes, 2010
: The fourth-generation cephalosporin, cefepime, has an antimicrobial spectrum that makes it a valuable antibiotic for empirical treatment of neutropenic fever.
Goossens, Herman   +5 more
core   +1 more source

Influence of Flunixin on the Disposition Kinetic of Cefepime in Goats

open access: yesAdvances in Pharmacological Sciences, 2014
The pharmacokinetic profile of cefepime (10 mg/kg b.w.) was studied following intravenous and intramuscular administration of cefepime alone and coadministered with flunixin (2.2 mg/kg b.w.) in goats.
Mohamed El-Hewaity
doaj   +1 more source

Cefepime exposure in prolonged or intermittent infusion in critically ill children

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Cefepime is commonly used in critically ill children for whom there is a high between‐subject variability. To reach the therapeutic pharmacokinetic (PK) target in critically ill patients, prolonged infusion of beta‐lactams seems to be the most efficient.
Marc Hobeika   +12 more
wiley   +1 more source

In Vitro Activity of Cefepime/AAI101 and Comparators against Cefepime Non-susceptible Enterobacteriaceae

open access: yes, 2015
We evaluated the in vitro potency of cefepime combined with AAI101, a novel extended-spectrum β-lactamase inhibitor, against a population of clinical Escherichia coli and Klebsiella pneumoniae collected from USA hospitals.
David P. Nicolau   +3 more
core   +1 more source

CEFPIROME. LITERATURE REVIEW

open access: yesПедиатрическая фармакология, 2014
Researchers around the world acknowledge a continuing growth of antibiotic resistance. Thus, it is especially important to select from a wide range of antibacterial agents in the pharmaceutical market the ones appropriate for specific regional ...
N. V. Dmitrieva
doaj   +1 more source

Home - About - Disclaimer - Privacy